Open AccessCost-Effectiveness of HRSA's Ryan White HIV/AIDS Program?
Author(s) -
Ravi Goyal,
Dara Lee Luca,
Pamela W. Klein,
Eric Morris,
Paul Mandsager,
Stacy M. Cohen,
Cindy Hu,
John R. Hotchkiss,
Jessica Gao,
Andrew Jones,
West Addison,
Margaret O'Brien-Strain,
Laura W. Cheever,
Boyd Gilman
Publication year - 2021
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002547
Subject(s) - counterfactual thinking , medicine , public health , human immunodeficiency virus (hiv) , health care , demography , program evaluation , gerontology , environmental health , family medicine , psychology , economic growth , economics , nursing , statistics , mathematics , social psychology , sociology
With an annual budget of more than $2 billion, the Health Resources and Services Administration's Ryan White HIV/AIDS Program (RWHAP) is the third largest source of public funding for HIV care and treatment in the United States, yet little analysis has been done to quantify the long-term public health and economic impacts of the federal program.